In the last trading session, 4.66 million shares of the Applied Therapeutics Inc (NASDAQ:APLT) were traded, and its beta was 1.89. Most recently the company’s share price was $0.57, and it changed around $0.07 or 14.69% from the last close, which brings the market valuation of the company to $66.68M. APLT currently trades at a discount to its 52-week high of $10.62, offering almost -1763.16% off that amount. The share price’s 52-week low was $0.43, which indicates that the current value has risen by an impressive 24.56% since then. We note from Applied Therapeutics Inc’s average daily trading volume that its 10-day average is 1.6 million shares, with the 3-month average coming to 3.97 million.
Applied Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.40. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended APLT as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Applied Therapeutics Inc is expected to report earnings per share of -0.18 for the current quarter.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT has showed a green trend with a performance of 14.69% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.6199 on recent trading dayincreased the stock’s daily price by 8.05%. The company’s shares are currently down -33.06% year-to-date, but still up 11.63% over the last five days. On the other hand, Applied Therapeutics Inc (NASDAQ:APLT) is 1.40% up in the 30-day period. We can see from the shorts that 19.53 million shares have been sold at a short interest cover period of 6.83 day(s).
The consensus price target as assigned by Wall Street analysts is $4.5, which translates to bulls needing to increase their stock price by 87.33% from its current value. Analyst projections state that APLT is forecast to be at a low of $4 and a high of $5.
Applied Therapeutics Inc (APLT) estimates and forecasts
The year-over-year growth rate is expected to be -94.47%, down from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 100k in revenue for the current quarter. 3 analysts expect Applied Therapeutics Inc to make 12.32M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 6,382.46%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.72%. Applied Therapeutics Inc earnings are expected to increase by 6.97% in 2025, but the outlook is positive 32.27% per year for the next five years.
APLT Dividends
Applied Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-Mar-17.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.68% of Applied Therapeutics Inc shares, and 107.37% of them are in the hands of institutional investors. The stock currently has a share float of 113.83%. Applied Therapeutics Inc stock is held by 162.0 institutions, with FRANKLIN RESOURCES INC being the largest institutional investor. By 2024-06-30, it held 70.7533% of the shares, which is about 10.21 million shares worth $47.69 million.
VR ADVISER, LLC, with 66.1112% or 9.54 million shares worth $44.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and T. Rowe Price Small-Cap Value Fund, Inc. were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.1 shares worth $1.78 million, making up 2.67% of all outstanding shares. On the other hand, T. Rowe Price Small-Cap Value Fund, Inc. held roughly 3.04 shares worth around $1.74 million, which represents about 2.61% of the total shares outstanding.
